Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients

Reproductive Biology and Endocrinology

Volumn 9, Issue , 2011, Pages

  Aloisi, Anna M ^a,b   Ceccarelli, Ilaria ^a   Carlucci, Maria ^a   Suman, Annalisa ^a   Sindaco, Gianfranco ^c   Mameli, Sergio ^d   Paci, Valentina ^c   Ravaioli, Laura ^c   Passavanti, Giandomenico ^e   Bachiocco, Valeria ^a   Pari, Gilberto ^b  

^a UNIVERSITY OF SIENA   (Italy)

^b Clinica San Carlo   (Italy)

^c Villa Serena Hospital   (Italy)

^d Territorial Department of Nephrology and Dialysis   (Italy)

^e MISERICORDIA HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROSTANOLONE; BACLOFEN; BUPIVACAINE; ESTRADIOL; FENTANYL; HYDROCORTISONE; MORPHINE; PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGED; ARTICLE; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL EVALUATION; HORMONE BLOOD LEVEL; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; MALE; PAIN ASSESSMENT; QUESTIONNAIRE; TREATMENT OUTCOME; CHEMICALLY INDUCED DISORDER; CHRONIC DISEASE; MIDDLE AGED; PAIN; PROSPECTIVE STUDY; QUALITY OF LIFE;

ADULT; AGED; CHRONIC DISEASE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPOGONADISM; MALE; MIDDLE AGED; MORPHINE; PAIN; PROSPECTIVE STUDIES; QUALITY OF LIFE; TESTOSTERONE;

EID: 79951570486     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-9-26     Document Type: Article

References (33)

1. Daniell HW, Lentz R, Mazer NA. Opel-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency. J Pain 2006, 7:200-210. 10.1016/j.jpain.2005.10.009, 16516826.
2. Furlan AD, Sandoval JA, Mailis-Gagnon A, Tunks E. Opioids for chronic non cancer pain: a meta-analysis of effectiveness and side effects. CMAJ 2006, 174:1589-1594. 1459894, 16717269.
3. Abs R, Verhelst J, Maeyaert J, Van Buyten JP, Opsomer F, Adriaensen H, Verlooy J, Van Havenbergh T, Smet M, Van Acker K. Endocrine consequences of long-term intrathecal administration of opioids. J Clin Endocrinol Metab 2000, 85:2215-2222. 10.1210/jc.85.6.2215, 10852454.
4. Aloisi AM, Pari G, Ceccarelli I, Vecchi I, Ietta F, Lodi L, Paulesu L. Gender-related effects of chronic non-malignant pain and opioid therapy on plasma levels of macrophage migration inhibitory factor (MIF). Pain 2005, 115:142-151. 10.1016/j.pain.2005.02.019, 15836977.
5. Daniell HW. Hypogonadism in men consuming sustained-action oral opioids. J Pain 2002, 3:377-384. 10.1054/jpai.2002.126790, 14622741.
6. Daniell HW. Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain. J Pain 2008, 9:28-36. 10.1016/j.jpain.2007.08.005, 17936076.
7. Fraser LA, morrison D, Morley-Forster P, Paul TL, Tokmakejian S, Larry Nicholson R, Bureau Y, Friedman TC, Van Uum SH. Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women. Exp Clin Endocrinol Diabetes 2009, 117:38-43. 10.1055/s-2008-1076715, 2953550, 18523930.
8. Ceccarelli I, De Padova AM, Fiorenzani P, Massafra C, Aloisi AM. Single opioid administration modifies gonadal steroids in both the CNS and plasma of male rats. Neuroscience 2006, 140:929-937. 10.1016/j.neuroscience.2006.02.044, 16580783.
9. Amini H, Ahmadiani A. In vivo evidence for an increase in 5 alpha-reductase activity in the rat central nervous system following morphine exposure. Int J Dev Neurosci 2005, 23:621-626. 10.1016/j.ijdevneu.2005.07.001, 16143488.
10. Moffat SD, Zonderman AB, Metter EJ, Kawas C, Blackman MR, Harman SM, Resnick SM. Free testosterone and risk for Alzheimer disease in older men. Neurology 2004, 62:188-193.
11. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001, 44:493-507. 10.1002/1529-0131(200103)44:3<493::AID-ANR95>3.0.CO;2-U, 11263762.
12. Harbuz MS, Perveen-Gill Z, Lightman SL, Jessop DS. A protective role for testosterone in adjuvant-induced arthritis. Br J Rheumatol 1995, 34:1117-1122. 10.1093/rheumatology/34.12.1117, 8608351.
13. Gaumond I, Arsenault P, Marchand S. The role of sex hormones on formalin-induced nociceptive responses. Brain Res 2002, 958:139-145. 10.1016/S0006-8993(02)03661-2, 12468038.
14. Aloisi AM, Ceccarelli I, Fiorenzani P, De Padova AM, Massafra C. Testosterone affects pain-related responses differently in male and female rats. Neurosci Lett 2004, 361:262-264. 10.1016/j.neulet.2003.12.023, 15135943.
15. Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men. J Clin Endocrinol Metab 2004, 89:2085-2098. 10.1210/jc.2003-032006, 15126525.
16. Huskisson EC, Jones J, Scott PJ. Application of Visual-Analogue Scales to the measurement of functional capacity. Rheumatol Rehabil 1976, 15:185-187. 10.1093/rheumatology/15.3.185, 968347.
17. De Benedittis G, Massei R, Nobili R, Pieri A. The Italian Pain Questionnaire. Pain 1988, 33:53-62. 10.1016/0304-3959(88)90203-5, 3380551.
18. Margolis RB, Tait RC, Krause SJ. A rating system for use with patient pain drawings. Pain 1986, 24:57-65. 10.1016/0304-3959(86)90026-6, 2937007.
19. Saccò M. Validazione culturale e linguistica di un questionario per definire il deficit androgenico nell'invecchiamento maschile. G Gerontol 2004, 52:74.
20. McNair DM. EdITS manual: profile of mood states 1971, Educational and Industrial Testing Service. San Diego.
21. Fontani G, Corradeschi F, Felici A, Alfatti F, Migliorini S, Lodi L. Cognitive and physiological effects of Omega-3 polyunsaturated fatty acid supplementation in healthy subjects. Eur J Clin Invest 2005, 35:691-699. 10.1111/j.1365-2362.2005.01570.x, 16269019.
22. Fava GA. Assessing depressive symptoms across cultures: Italian validation of the CES-D self-rating scale. J Clin Psychol 1983, 39:249-251. 10.1002/1097-4679(198303)39:2<249::AID-JCLP2270390218>3.0.CO;2-Y, 6841626.
23. Bos MJ, Lindén T, Koudstaal PJ, Hofman A, Skoog I, Breteler MM, Tiemeier H. Depressive symptoms and risk of stroke: the Rotterdam Study. J Neurol Neurosur Psychiatry 2008, 79:997-1001.
24. Apolone G, Mosconi P. The Italian SF-36 Health Survey: translation, validation and norming. J Clin Epidemiol 1998, 51:1025-1036. 10.1016/S0895-4356(98)00094-8, 9817120.
25. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab 1999, 84:3666-3672. 10.1210/jc.84.10.3666, 10523012.
26. Fabbri A, Giannetta E, Lenzi A, Isidori AM. Testosterone treatment to mimic hormone physiology in androgen replacement therapy. A view on testosterone gel and other preparations available. Expert Opin Biol Ther 2007, 7:1093-1106. 10.1517/14712598.7.7.1093, 17665996.
27. Ballantyne JC. Chronic pain following treatment for cancer: the role of opioids. Oncologist 2003, 8:567-575. 10.1634/theoncologist.8-6-567, 14657535.
28. Delitala G, Giusti M, Mazzocchi G, Granziera L, Tarditi W, Giordano G. Participation of endogenous opiates in regulation of the hypothalamic-pituitary-testicular axis in normal men. J Clin Endocrinol Metab 1983, 57:1277-1281. 10.1210/jcem-57-6-1277, 6415088.
29. Vuong C, Van Uum HM, O'Dell LE, Lutfy K, Friedman TC. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev 2010, 31:98-132. 10.1210/er.2009-0009, 2852206, 19903933.
30. Fabbri A, Jannini EA, Gnessi L, Ulisse S, Moretti C, Isidori A. Neuroendocrine control of male reproductive function. The opioid system as a model of control at multiple sites. J Steroid Biochem 1989, 32:145-150. 10.1016/0022-4731(89)90155-6, 2643737.
31. Ceccarelli I, Rossi A, Maddalena M, Weber E, Aloisi AM. Effects of morphine on testosterone levels in rat C6 glioma cells: modulation by anastrozole. J Cell Physiol 2009, 221:1-4. 10.1002/jcp.21830, 19492405.
32. Aloisi AM, Ceccarelli I, Fiorenzani P, Maddalena M, Rossi A, Tomei V, Sorda G, Danielli B, Rovini M, Cappelli A, Anzini M, Giordano A. Aromatase and 5-alpha reductase gene expression: modulation by pain and morphine treatment in male rats. Mol Pain 2010, 6:69. 10.1186/1744-8069-6-69, 2978140, 20977699.
33. Aloisi AM, Buonocore M, Merlo L, Galandra C, Sotgiu A, Bacchella L, Ungaretti M, Demartini L, Bonezzi C. Chronic pain therapy and hypothalamic-pituitary-adrenal axis impairment. PNEC 2011,